Literature DB >> 6706860

Suppressibility of the 2f1-f2 stimulated acoustic emissions in gerbil and man.

A M Brown, D T Kemp.   

Abstract

The suppression tuning properties of the oto-acoustic distortion product emission, 2f1-f2 have been measured in the ear canal of gerbil and man. The results show the acoustic response to be suppressible in a similar, frequency-dependent manner in both species. Frequencies near to those of the stimulating tones are most effective in suppressing the response. Derived iso-suppression tuning curves have Q10dB values of between 1 and 6. Suppressor tones having frequencies near to f2 (the higher frequency stimulus) make a contribution to the tuning curve which is largely independent of the stimulus intensity and the frequency ratio between the two primary tones. Suppressors having f1-associated frequencies produce a variable amount of suppression depending on the stimulus parameters chosen. No specific suppression feature could be associated with suppressors near to 2f1-f2. The frequency selectivity of the acoustic DP generation mechanism shown by this study indicates a close association with the transduction mechanism. The demonstration of comparable signals in gerbil and man facilitates the direct transfer of laboratory results to the study of human ears.

Entities:  

Mesh:

Year:  1984        PMID: 6706860     DOI: 10.1016/0378-5955(84)90092-3

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  30 in total

1.  Influence of calibration method on distortion-product otoacoustic emission measurements: I. test performance.

Authors:  Sienna R Burke; Abigail R Rogers; Stephen T Neely; Judy G Kopun; Hongyang Tan; Michael P Gorga
Journal:  Ear Hear       Date:  2010-08       Impact factor: 3.570

2.  High-frequency two-tone distortions from the ear of the mustached bat, Pteronotus parnellii reflect enhanced cochlear tuning.

Authors:  M Kössl
Journal:  Naturwissenschaften       Date:  1992-09

3.  Predictors of hearing threshold levels and distortion product otoacoustic emissions among noise exposed young adults.

Authors:  N S Seixas; S G Kujawa; S Norton; L Sheppard; R Neitzel; A Slee
Journal:  Occup Environ Med       Date:  2004-11       Impact factor: 4.402

4.  Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.

Authors:  Garnett P McMillan; Dawn Konrad-Martin; Marilyn F Dille
Journal:  Int J Audiol       Date:  2012-06-07       Impact factor: 2.117

5.  An alternate approach to constructing distortion product otoacoustic emission (DPOAE) suppression tuning curves.

Authors:  Tiffany A Johnson; Stephen T Neely; Darcia M Dierking; Brenda M Hoover; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2004-12       Impact factor: 1.840

6.  Influence of primary-level and primary-frequency ratios on human distortion product otoacoustic emissions.

Authors:  Tiffany A Johnson; Stephen T Neely; Cassie A Garner; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2006-01       Impact factor: 1.840

7.  Comparison of compound action potential audiograms with distortion product otoacoustic emissions in experimentally induced hydrops.

Authors:  K C Horner
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

8.  The role of suppression in psychophysical tone-on-tone masking.

Authors:  Joyce Rodríguez; Stephen T Neely; Harisadhan Patra; Judy Kopun; Walt Jesteadt; Hongyang Tan; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2010-01       Impact factor: 1.840

9.  Low-frequency and high-frequency distortion product otoacoustic emission suppression in humans.

Authors:  Michael P Gorga; Stephen T Neely; Darcia M Dierking; Judy Kopun; Kristin Jolkowski; Kristin Groenenboom; Hongyang Tan; Bettina Stiegemann
Journal:  J Acoust Soc Am       Date:  2008-04       Impact factor: 1.840

10.  Multifrequency forcing of a Hopf oscillator model of the inner ear.

Authors:  K A Montgomery
Journal:  Biophys J       Date:  2008-04-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.